Clinical Trials Browser

Phase 2 × Unknown × Neoplasms × Clear all

NCT05289856 2024-03-07

Cabozantinib in Combination With Avelumab in Patients Refractory to Standard Chemotherapy With Advanced Neuroendocrine Neoplasias G3 (NEN G3)

Phase 2 Unknown

Neoplasms

NCT03549273 2024-02-07

Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

Phase 2 Unknown

Carcinoma, Uterine Cervical Dysplasia, Neoplasms, Neoplasms, Glandular and Epithelial

NCT05229029 2024-01-19

TCM

Phase 2 Unknown

Fatigue, Neoplasms

NCT03935256 2023-12-18

Adjuvant Sequential & Concurrent CarboTaxol + Radiotherapy for High Risk Endometrial Cancer

Phase 2 Unknown

Neoplasms, Endometrial Neoplasms

NCT05150236 2023-12-15

ANZUP2001

Phase 2 Unknown

Genital Neoplasms, Male, Neoplasms, Neoplasms by Site, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

NCT05876806 2023-11-30

Dabrafenib Plus Trametinib in Patients With Advanced Solid Tumor Having BRAF V600E Mutation or Clinically Actionable BRAF Gene Alterations

Phase 2 Unknown

Neoplasms

NCT04758650 2023-11-18

MITRAS

Phase 2 Unknown

Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Sarcoidosis, Carotid Stenosis

NCT05311709 2023-11-09

SOLUCOM

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

NCT06092606 2023-10-23

A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients

Phase 2 Unknown

Arrhythmias, Cardiac, Heart Failure, Neoplasms

NCT04717674 2023-10-03

[18F]FPIA

Phase 2 Unknown

Neoplasms

NCT06047860 2023-09-21

A Clinical Study of Recombinant Human Vascular Endothelial Inhibitor in Combination With PRaG for Advanced Refractory Non-small Cell Lung Cancer

Phase 2 Unknown

Neoplasms

NCT02858921 2023-08-30

Neo Trio

Phase 2 Unknown

Melanoma, Neoplasms

NCT05986981 2023-08-14

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

Phase 2 Unknown

Medullary cystic kidney disease 1, Neoplasms

NCT05904457 2023-06-15

BRISK

Phase 2 Unknown

Neoplasm Metastasis, Neoplasms

NCT03820310 2023-05-24

Clinical Trial of Autologous Tcm Immunotherapy in ICC

Phase 2 Unknown

Gastrointestinal

Neoplasms, Cholangiocarcinoma

NCT04840004 2023-04-05

Efficacy and Safety of PVT-1 Treatment in Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT05790447 2023-03-30

Thymalfasin-based PRaG Mode for Advanced Refractory Solid Tumors

Phase 2 Unknown

Neoplasms

NCT00996983 2023-03-24

ZIDON

Phase 2 Unknown

Neoplasms, Neuralgia, Pain, Pain, Intractable

NCT03803436 2023-03-16

COLT

Phase 2 Unknown

Gastrointestinal

Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT04985721 2023-03-15

IMPARP-HRD

Phase 2 Unknown

Neoplasms

NCT03561259 2023-02-16

OPTIMUM

Phase 2 Unknown

Neoplasms, Neuroblastoma, Neuroectodermal Tumors

NCT05686213 2023-02-08

ExeNTrO

Phase 2 Unknown

Neoplasms

NCT04810156 2022-12-14

I-HEP

Phase 2 Unknown

Hepatitis, Neoplasms, Chemical and Drug Induced Liver Injury

NCT04225767 2022-12-13

CaEP-R

Phase 2 Unknown

Neoplasms

NCT02357134 2022-12-07

High-Flow Oxygen in Reducing Shortness of Breath Caused by Exercise in Patients With Cancer

Phase 2 Unknown

74 enrolled 16 charts

Dyspnea, Neoplasms

NCT05291390 2022-11-29

Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02461849 2022-06-15

Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy

Phase 2 Unknown

Neoplasms

NCT03944447 2022-06-02

OMNI-Can

Phase 2 Unknown

200,000 enrolled

Classical hematology

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

NCT05380479 2022-05-18

Mirtazapine Versus Megestrol Acetate in Treatment of Anorexia-cachexia in Advanced Cancer Patients.

Phase 2 Unknown

Anorexia, Cachexia, Neoplasms

NCT02366884 2022-04-06

Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011)

Phase 2 Unknown

Neoplasms

NCT05147493 2022-03-29

A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma and Severe Renal Impairment

Phase 2 Unknown

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Renal Insufficiency, Neoplasms, Plasma Cell

NCT05298683 2022-03-28

A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received One Prior Line of Therapy Containing Lenalidomide and a Proteasome Inhibitor

Phase 2 Unknown

Blood Protein Disorders, Hematologic Diseases, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Renal Insufficiency, Neoplasms, Plasma Cell

NCT03759496 2022-03-23

Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer

Phase 2 Unknown

Urinary Bladder Neoplasms, Neoplasms

NCT03239015 2022-03-04

Efficacy and Safety of Precision Therapy in Refractory Tumor

Phase 2 Unknown

Neoplasms

NCT03570437 2022-03-02

COPELIA

Phase 2 Unknown

GynecologicSarcoma

Carcinosarcoma, Neoplasms, Endometrial Neoplasms

NCT05241132 2022-02-15

Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary

Phase 2 Unknown

Neoplasms

NCT03186404 2022-02-08

SPARE-HF

Phase 2 Unknown

Heart Failure, Neoplasms, Cardiotoxicity

NCT02595320 2021-12-20

X7-7

Phase 2 Unknown

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms

NCT05097378 2021-10-28

PREMIUM

Phase 2 Unknown

Melanoma, Neoplasms

NCT04593563 2021-10-15

The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder

Phase 2 Unknown

Depressive Disorder, Major, Neoplasms

NCT04547829 2021-09-02

Safety and Efficacy of PEG-rhG-CSF in Preventing Neutropenia in Children With Tumor After Chemotherapy

Phase 2 Unknown

Neoplasms

NCT03564548 2021-07-28

REBORN

Phase 2 Unknown

Neoplasms

NCT04780854 2021-07-28

Drug Repurposing for the Prevention of Chemotherapy-induced Peripheral Neuropathy (CIPN)

Phase 2 Unknown

Neoplasms

NCT01676259 2021-07-02

PROTACT

Phase 2 Unknown

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT04907864 2021-06-01

MIRACLE

Phase 2 Unknown

GastrointestinalThoracic

Biliary Tract Neoplasms, Cachexia, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT02978014 2021-04-19

POPS

Phase 2 Unknown

Coitus, Neoplasms

NCT02029937 2021-01-14

High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia

Phase 2 Unknown

Neoplasms

NCT04710472 2021-01-14

MentorA1

Phase 2 Unknown

Neoplasms

NCT04695223 2021-01-06

Arsenic Trioxide for Structural p53 Mutations

Phase 2 Unknown

Neoplasms

NCT04647838 2020-12-02

Tepotinib in Solid Tumors Harboring MET Alterations

Phase 2 Unknown

Neoplasms